Continuing Pharmacy Education / CE Master List / Doppelgangers, Imposters, and New Kids on the Block LIVE ENCORE WEBINARS December 22 – 30, 2025
Please use this button to register in our system as a new user, or to purchase a CE Activity.
For free CE's, returning users can simply click the "TAKE TEST/EVALUATION" button on the right.
Please use this button when you have completed the CE Activity and are ready to take the quiz and complete the evaluation.

Doppelgangers, Imposters, and New Kids on the Block LIVE ENCORE WEBINARS December 22 – 30, 2025

Henry A. Palmer CE Finale 2025

Henry A. Palmer CE Finale, named for beloved professor and mentor, Dr. Henry A. Palmer, is a continuing education program offered at the end of each calendar year. Held during December, the program helps pharmacists fulfill their last-minute CE requirements. The program is an ala carte program offering a variety of presentations covering contemporary issues in pharmacy practice/therapeutics. Pharmacists may enroll in one or more [up to 8] hours of continuing education.

REGISTRATION LINK

REGISTER HERE

Activity Support:  There is no funding for this program.

 

LIVE Encore Webinars cost $30 each.

ACPE UANs

Pharmacist: 0009-0000-25-062-L03-P      Pharmacist: 0009-0000-25-063-L99-P

Pharmacist: 0009-0000-25-064-L01-P      Pharmacist: 0009-0000-25-065-L01-P

Pharmacist: 0009-0000-25-066-L05-P      Pharmacist: 0009-0000-25-067-L01-P

Pharmacist: 0009-0000-25-068-L01-P      Pharmacist: 0009-0000-25-069-L06-P

Accreditation Hours

Each CE is 1 contact hour

(.10 CEU's)

Accreditation Statements

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Statements of credit for the online activities:

ACPE UAN 0009-0000-25-062-L03-P

ACPE UAN 0009-0000-25-063-L99-P

ACPE UAN 0009-0000-25-064-L01-P

ACPE UAN 0009-0000-25-065-L01-P

ACPE UAN 0009-0000-25-066-L05-P

ACPE UAN 0009-0000-25-067-L01-P

ACPE UAN 0009-0000-25-068-L01-P

ACPE UAN 0009-0000-25-069-L06-P

- will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

 

Disclosure of Discussions of Off-label and Investigational Drug Use

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Faculty 

Jeannette Y. Wick, RPh, MBA, Director of the Office of Professional Pharmacy Development, University of Connecticut School of Pharmacy, Storrs, CT

Jennifer Luciano, PharmD, Director of Office of Experiential Education, University of Connecticut School of Pharmacy, Storrs, CT

William L. Baker, PharmD, FCCP, FACC, FHFSA, Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT

Devra Dang, PharmD, CDCES, FNAP, Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT  

Michael White, PharmD, FCP, FCCP, FASHP, Distinguished Professor and Chair, Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT

Kelsey Giara, PharmD, Freelance Medical Writer, Pelham, NH

Kristin Waters, PharmD, BCPS, BCPP, Assistant Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT

Jeff Aeschlimann, PharmD, University of Connecticut, Storrs, CT

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

All the speakers have no relationships with ineligible companies.

 

SCHEDULE/TOPICS/LEARNING OBJECTIVES

Henry A. Palmer CE FINALE 2025 LIVE ENCORE WEBINARS - streaming on Webex in Eastern Standard Time

 

Monday, December 22, 12:00 (Noon) - 1:00 pm EST

NKOTB: New and Emerging Roles for GLP-1-Based Medications

Devra Dang, PharmD, CDCES, FNAP, Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT  

0009-0000-25-065-L01-P (0.1 CEU or 1 contact hour) (Knowledge-based)

At the conclusion of this presentation, pharmacists will be able to
  • List recent FDA-approved indications for GLP-1-based medications
  • Recognize proposed mechanisms by which GLP-1-based medications may impact conditions beyond type 2 diabetes and adiposity-based chronic disease
  • Describe key findings from major clinical trials evaluating new therapeutic potential of GLP-1-based medications

           

          *

          Monday, December 22, 7:00 -8:00 pm EST

          Hormone Therapy’s Twin Faces: Sorting Science from Misconception

          Kelsey Giara, PharmD, Freelance Medical Writer, Pelham, NH

          0009-0000-25-067-L01-P  (0.1 CEU or 1 contact hour (Application-based)

          At the conclusion of this presentation, pharmacists will be able to
          • Discuss the clinical evidence on safety, efficacy, and patient outcomes for hormone replacement therapy (HRT), highlighting areas of misconception or confusion
          • Compare HRT options and bioidenticals, including mechanisms of action, formulations, and regulatory pathways
          • Apply guidelines and evidence-based recommendations to individualize patient counseling and therapeutic decision-making when managing HRT

             

            *

            Monday, December 22, 8:10 – 9:10 pm EST

            LAW: Identifying Imposters: Counterfeit Drugs in the Pharmacy Distribution Chain

            Jeannette Y. Wick, RPh, MBA, Director of the Office of Professional Pharmacy Development, University of Connecticut School of Pharmacy, Storrs, CT

            0009-0000-25-062-L03-P (0.1 CEU or 1 contact hour) (Application-based)

            At the conclusion of this presentation, pharmacists will be able to
            • Define the terms “counterfeit” and "spurious" drugs
            • Discuss the prevalence of counterfeiting globally and in the United States
            • List factors that contribute to drug counterfeiting
            • Discuss the Drug Supply Chain Security Act (DSCSA) and its implications for the drug supply distribution chain’s integrity
            • Identify steps that reduce the risk of suspect product being delivered to the pharmacy and to patients

               

              *

              Tuesday, December 23, 12:00 (noon) -1:00 pm EST

              PATIENT SAFETY: Biosimilar Doppelgangers

              Michael White, PharmD, FCP, FCCP, FASHP, Distinguished Professor and Chair, Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT

              0009-0000-25-066-L05-P (0.1 CEU or 1 contact hour) (Application-based)

              At the conclusion of this presentation, pharmacists will be able to
              • Compare and contrast a small molecule drug from a biological drug
              • Compare and contrast how a reference biologic drug compares with its biosimilar
              • Describe where a pharmacist would identify a biosimilar product and the legal implications of a biosimilar achieving interchangeable status with a reference product
              • Describe the nocebo effect and how to prevent it from occurring
              • Apply the knowledge from the objectives above to specific patient care scenarios in the self-assessment questions

                 

                *

                Tuesday, December 23, 7 pm – 8 pm EST

                IMMUNIZATION: Mountebanks, Grifters, and Frauds (Oh My!): An Update on the Management of Vaccine-Preventable Illnesses in 2025

                Jeff Aeschlimann, PharmD, University of Connecticut, Storrs, CT

                0009-0000-25-069-L06-P (0.1 CEU or 1 contact hour) (Application-based)

                At the conclusion of this presentation, pharmacists will be able to
                • Describe at least one important change (or proposed change) in childhood and adult vaccination recommendations put forth by the CDC and/or ACIP
                • Given a patient who asks about receiving respiratory virus or bacteria vaccinations (e.g., Influenza, COVID-19, respiratory syncytial virus (RSV), pneumococcal), outline important differences between multiple products when they exist
                • Identify evidence-based pharmacotherapeutic treatments for common vaccine-preventable illnesses

                 

                *

                Monday, December 29, 12:00 (Noon) – 1:00 pm EST

                Breaking the Mold: Novel Mechanisms in Psychiatry’s New Kids on the Block

                Kristin Waters, PharmD, BCPS, BCPP, Assistant Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT

                0009-0000-25-068-L01-P  (0.1 CEU or 1 contact hour) (Application-based)

                At the conclusion of this presentation, pharmacists will be able to
                • Describe the unique mechanisms of action of xanomeline-trospium in the management of schizophrenia and dextromethorphan-containing medications in the management of major depressive disorder
                • Distinguish between adverse effect profiles of new psychiatric medications compared to traditional antipsychotics and antidepressants
                • Identify appropriate candidates for new psychiatric medications based on knowledge of efficacy, safety, and patient-specific factors

                   

                  *

                  Monday, December 29, 7 – 8 pm EST

                  LAW: Identifying Imposters: Counterfeit Drugs in the Pharmacy Distribution Chain

                  Jeannette Y. Wick, RPh, MBA, Director of the Office of Professional Pharmacy Development, University of Connecticut School of Pharmacy, Storrs, CT

                  0009-0000-25-062-L03-P (0.1 CEU or 1 contact hour) (Application-based)

                  At the conclusion of this presentation, pharmacists will be able to
                  • Define the terms “counterfeit” and "spurious" drugs
                  • Discuss the prevalence of counterfeiting globally and in the United States
                  • List factors that contribute to drug counterfeiting
                  • Discuss the Drug Supply Chain Security Act (DSCSA) and its implications for the drug supply distribution chain’s integrity
                  • Identify steps that reduce the risk of suspect product being delivered to the pharmacy and to patients

                     

                    *

                    Tuesday, December 30, 12:00 (Noon) – 1:00 pm EST

                    NKOTB: 2025 Updates on Management of Hypertension in Adults

                    William L. Baker, PharmD, FCCP, FACC, FHFSA, Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT

                    0009-0000-25-064-L01-P (0.1 CEU or 1 contact hour) (Application-based)

                    At the conclusion of this presentation, pharmacists will be able to
                    • Review the 2025 hypertension guidelines
                    • Compare the updated recommendations to the prior guidelines
                    • Review the evidence supporting the guideline changes

                       

                      *

                      Tuesday, December 30, 7 – 8 pm EST

                      Step by Step: Tackling Imposter Syndrome in Every Transition

                      Jennifer Luciano, PharmD, Director of Office of Experiential Education, University of Connecticut School of Pharmacy, Storrs, CT

                      0009-0000-25-063-L99-P  (0.1 CEU or 1 contact hour) (Application-based)

                      At the conclusion of this presentation, pharmacists will be able to
                      • Recognize the signs and symptoms of imposter syndrome as they commonly present in pharmacy practice and education, including during career transitions such as rotations, residency, and new professional roles
                      • Examine the personal, academic, and systemic factors that contribute to imposter syndrome among pharmacists and pharmacy students, with emphasis on high-performance expectations and professional identity formation
                      • Identify practical, evidence-based strategies to manage and overcome imposter syndrome, fostering resilience, confidence, and professional growth within pharmacy practice and education

                       

                       

                      Refunds and Cancellations: The registration fee, less a $10 processing fee, is refundable for those who email Heather.Kleven@uconn.edu to cancel their registration prior to the program. After that time, no refund is available.

                      Location: The Henry A. Palmer C.E. Finale ENCORE WEBINARS are virtual only. You must sign in to the Webex link at the designated time using the link in your confirmation email.

                      Continuing Education Units

                      The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of Credit will be awarded at CE Finale based on full sessions attended and completed online evaluations.

                      Please Note: Pharmacists who wish to receive credit for the presentations MUST ACCURATELY complete the registration and online evaluations within 45 days of the live program (before February 1, 2026).  Participants are accountable for their own continuing education requirements for license renewal and are required to follow up with Heather.Kleven@uconn.edu to resolve a discrepancy in a timely manner. PLEASE CHECK YOUR CPE MONITOR PROFILE within 3 days of submission to ensure that your credits have been properly uploaded.  Requests for exceptions will be handled on a case-by-case basis and may result in denial of credit.

                      Registration Fees: 50% discount for UConn faculty/preceptors

                      REGISTRATION LINK

                      REGISTER HERE